Last updated: February 11, 2026
Sponsor: McMaster University
Overall Status: Completed
Phase
N/A
Condition
Brain Function
Treatment
Low Dose β-OHB
Placebo
High Dose β-OHB
Clinical Study ID
NCT06032156
kCBF
Ages 18-35 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Between the ages of 18 and 35
Exclusion
Exclusion Criteria:
Presence of obesity (body mass index > 30 kg/m^2)
Presence of known cardiovascular disease
Presence of type 2 diabetes
History of cardiovascular events requiring hospitalization (i.e., heart attack)
History of concussion(s) with persistent symptoms
Currently following a ketogenic diet and/or taking ketone body supplements
Study Design
Total Participants: 20
Treatment Group(s): 3
Primary Treatment: Low Dose β-OHB
Phase:
Study Start date:
November 08, 2023
Estimated Completion Date:
August 30, 2024
Connect with a study center
McMaster University
Hamilton, Ontario L8S 4K1
CanadaSite Not Available
McMaster University
Hamilton 5969782, Ontario 6093943 L8S 4K1
CanadaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.